Invention in the REGENERATIVE MEDICINE is what we do every day, benefits of patients is our final goal

Our Products

Home > Products

Cata #: Name of Product: Price:
HRP-3280 Recombinant Human DEL1 Protein $300

Recombinant Human DEL1 Protein

Product Name: Recombinant Human DEL1 Protein
Catalog #:  HRP-3280
Manufacture:  LD Biopharma, Inc.

Human EGF-like repeat and discoidin I-like domain-containing protein 3 (DEL-1) gene encode a secreted protein which promotes adhesion of endothelial cells through interaction with the αv/β3 integrin receptor. It inhibits formation of vascular-like structures. DEL-1 may also be involved in regulation of vascular morphogenesis of remodeling in embryonic development. Recent data indicated that DEL-1 increased RUNX1 and FOXP3 expression in human CD4+CD25– conventional T (Tconv) cells, promoting their conversion into induced Tregs with increased stability, accompanied by increased demethylation of the Treg-specific demethylated region (TSDR) and enhanced suppressive activity. 

Full-length secreted form of human DEL1 cDNA (24 – 480aa) was constructed with codon optimization gene synthesis and expressed with a human N-terminalT7-His-TEV cleavage site Tag (29aa) fusion. This protein was expressed in E. coli as inclusion bodies. The final product was refolded using our unique “temperature shift inclusion body refolding” technology and chromatographically purified.

Gene Symbol:  DEL1 (EDIL3) 
Accession Number:  NP_005702
Species:  Human
Package Size:  50 µg / Vial   
Composition: 1mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose and DTT.
Storage: In Liquid. Keep at -80°C for long term storage. Product is stable at 4 °C for at least 30 days.
Key Reference:

Xiaofei Li et al, The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolution, Journal of Clinical Investigation (2020). DOI: 10.1172/JCI137530

Kourtzelis I, et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. NatImmunol. 2019; 20(1):40–49.

Hanayama R, et al.,Expression of developmental endothelial locus-1 in a subset of macrophages for engulfment of apoptotic cells. J Immunol. 2004; 172(6):3876–3882.

  1. May be used for in vitro DEL1 mediated T lymphocyte or endothelial cell activities regulation study with this protein either as soluble factor or as coating matrix protein. 
  2. May be used for DEL1 protein-protein interaction assay.
  3. Potential therapeutic protein, which may be used as anti-inflammatory reagent for various diseases therapy, such as multiple sclerosis or allergic asthma et al.
  4. As native human DEL1 antigen for its specific antibody production.
Quality Control: Purity: > 92 % by SDS-PAGE.
Recombinant Protein Sequence:


Download Datasheet